Zobrazeno 1 - 10
of 123
pro vyhledávání: '"C Shivaprasad"'
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 22, Iss 1, Pp 57-61 (2018)
Context: Electrochemical skin conductance (ESC) test is a widely accepted objective technique for quantitatively assessing sudomotor dysfunction, which is one of the earliest-detected neurophysiologic abnormalities in diabetic patients with distal sy
Externí odkaz:
https://doaj.org/article/c2c23218a5dd4affbadf1639c6141ea5
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 22, Iss 3, Pp 335-338 (2018)
Context: Health-related quality of life (HRQL) is an important outcome measure for various diseases, although there are sparse data regarding HRQL among Indian patients with hypothyroidism. Aims: This study aimed to assess HRQL among Indian patients
Externí odkaz:
https://doaj.org/article/007d3d641007410ab43d6e9d7072b654
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 21, Iss 1, Pp 76-79 (2017)
Background: Hungry bone syndrome is a common complication of surgery for primary hyperparathyroidism in India which often leads to prolonged hospitalization. There are varying reports on the use and efficacy of bisphosphonates in the prevention of hu
Externí odkaz:
https://doaj.org/article/707819ba863147baa04978ce1dd372a1
Autor:
Anish Kolly, C Shivaprasad, Annie A Pulikkal, Sridevi Atluri, Vijaya Sarathi, C S Dwarakanath
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 21, Iss 4, Pp 510-514 (2017)
Aim of Study: The aim is to study the prevalence and pattern of serine protease inhibitor Kazal type 1 (SPINK1) gene variations in patients with fibrocalculous pancreatic diabetes (FCPD) using whole gene sequencing. Materials and Methods: A total of
Externí odkaz:
https://doaj.org/article/3bdd620d4a7f46c38fb487b711796933
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 20, Iss 2, Pp 233-237 (2016)
Context: Celiac disease (CD) is a commonly encountered autoimmune condition in patients with type 1 diabetes (T1D). There is sparse data on the seroprevalence of immunoglobulin A (IgA) transglutaminase (tTG) in T1D patients of South Indian origin. Ai
Externí odkaz:
https://doaj.org/article/a37154535e81404fb59032c55610be41
Autor:
C Shivaprasad, K M Prasanna Kumar
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 19, Iss 1, Pp 84-88 (2015)
Introduction: Data from several studies suggest that pretreatment with antithyroid drugs (ATD) before 131 I increases the risk of treatment failure. This effect has been demonstrated more consistently with propylthiouracil than with carbimazole (CMZ)
Externí odkaz:
https://doaj.org/article/7c41a41eb8294b12a329d4306018d725
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 11, Iss 7, Pp OC15-OC20 (2017)
Introduction: Hypothyroidism is a common endocrine disorder with a reported prevalence of 4%-10%. Previous studies have reported significant gaps in the basic knowledge about the condition in hypothyroid patients. It has also been observed that f
Externí odkaz:
https://doaj.org/article/a0cc0c8cddde41f1bb4c3bbcaaa56ad1
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 18, Iss 3, Pp 345-349 (2014)
Introduction: Zinc transporter-8 (ZnT8) is an islet cell secretory granule membrane protein recently identified as an autoantigen in type 1 diabetes (T1D). The aim of this study was to estimate the prevalence of antibodies to ZnT8 (ZnT8A) in juvenile
Externí odkaz:
https://doaj.org/article/68fa26774e4c4bb6a36af38012e6758b
Autor:
C Shivaprasad
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 15, Iss 7, Pp 203-207 (2011)
Sheehan′s syndrome (SS) is postpartum hypopituitarism caused by necrosis of the pituitary gland. It is usually the result of severe hypotension or shock caused by massive hemorrhage during or after delivery. Patients with SS have varying degrees of
Externí odkaz:
https://doaj.org/article/11ee45c3cb5d4936ab6cbb893f877910
Autor:
C Shivaprasad, Sanjay Kalra
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 15, Iss 5, Pp 17-24 (2011)
Bromocriptine mesylate quick-release was approved by the Food and Drug Administration (FDA) in May 2009, for the treatment of type 2 diabetes. Bromocriptine is thought to act on the circadian neuronal activities in the hypothalamus, to reset an abnor
Externí odkaz:
https://doaj.org/article/5d53d4435cb341d3ac7f552ab9349412